AUTHOR=Duarte-Díaz Andrea , Perestelo-Pérez Lilisbeth , Rivero-Santana Amado , Peñate Wenceslao , Álvarez-Pérez Yolanda , Ramos-García Vanesa , González-Pacheco Himar , Goya-Arteaga Libertad , de Bonis-Braun Miriam , González-Martín Silvia , Ramallo-Fariña Yolanda , Carrion Carme , Serrano-Aguilar Pedro 

TITLE=The relationship between patient empowerment and related constructs, affective symptoms and quality of life in patients with type 2 diabetes: a systematic review and meta-analysis

JOURNAL=Frontiers in Public Health

VOLUME=Volume 11 - 2023

YEAR=2023

URL=https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2023.1118324

DOI=10.3389/fpubh.2023.1118324

ISSN=2296-2565

ABSTRACT=The aim of this review is to assess the relationship between empowerment, affective symptoms and quality of life on patients with type 2 diabetes. A systematic review of the literature was conducted according to the PRISMA guidelines. Meta-analyses of correlation coefficients, subgroup analyses and meta-regression were performed. There is a weak-to-moderate inverse association between patient empowerment and anxiety (r = -0.22) and depression (r = -0.29). Moreover, patient empowerment was moderately negatively correlated with distress (r = -0.31) and moderately positively correlated with general quality of life (r = 0.32). Small associations between empowerment and both mental (r = 0.23) and physical quality of life (r = 0.13) were also reported. Patient empowerment is negatively correlated with affective symptoms and positively correlated with quality of life. This evidence mostly proceeds from cross-sectional studies. High-quality prospective studies are needed not only to better understand the role of patient empowerment but to assess causal associations. The results of our study highlight the importance of patient empowerment in diabetes care. Thus, it should be considered in the design, development and implementation of effective interventions and policies aimed at improving psychosocial outcomes in patients with type 2 diabetes.